We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$37.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$27.4M |
| 4 |
Home Depot
HD
|
+$22.7M |
| 5 |
Cisco
CSCO
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$23.6M |
| 2 |
TJX Companies
TJX
|
+$19.3M |
| 3 |
FedEx
FDX
|
+$16.4M |
| 4 |
Intuit
INTU
|
+$14.7M |
| 5 |
Corning
GLW
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.19% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Federal Realty Investment Trust
FRT
$10.9B
| $957K | 0.02% |
7,565
| – | – |
|
602
CarMax
KMX
$8.27B
| $946K | 0.02% |
12,983
+1,787
| +16% | +$119K |
|
|
KL
603
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $935K | 0.01% |
44,197
| – | – |
|
604
Robert Half
RHI
$3.61B
| $932K | 0.01% |
14,319
-1,197
| -8% | -$75.9K |
|
|
CALA
605
DELISTED
Calithera Biosciences, Inc
CALA
| $900K | 0.01% |
9,000
| – | – |
|
606
Ulta Beauty
ULTA
$20.4B
| $893K | 0.01% |
3,824
-37,040
| -91% | -$8.95M |
|
607
Fidelity National Financial
FNF
$13.9B
| $891K | 0.01% |
24,626
| – | – |
|
608
Aurinia Pharmaceuticals
AUPH
$1.97B
| $887K | 0.01% |
157,500
+39,500
| +33% | +$220K |
|
|
LMNX
609
DELISTED
Luminex Corp
LMNX
| $886K | 0.01% |
30,000
-8,000
| -21% | -$205K |
|
610
Bread Financial
BFH
$4.21B
| $881K | 0.01% |
4,734
-64
| -1% | -$10.9K |
|
|
OMED
611
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $878K | 0.01% |
380,000
+60,000
| +19% | +$175K |
|
612
OR Royalties Inc
OR
$5.47B
| $870K | 0.01% |
91,914
| – | – |
|
613
Expedia Group
EXPE
$31.2B
| $869K | 0.01% |
7,231
-28
| -0.4% | -$3.23K |
|
614
Jacobs Solutions
J
$15.9B
| $855K | 0.01% |
16,282
-10,294
| -39% | -$529K |
|
615
ManpowerGroup
MAN
$2.39B
| $845K | 0.01% |
9,820
-5,220
| -35% | -$513K |
|
616
Take-Two Interactive
TTWO
$43B
| $837K | 0.01% |
7,068
-520
| -7% | -$56.6K |
|
|
CIT
617
DELISTED
CIT Group Inc.
CIT
| $833K | 0.01% |
16,520
-2,315
| -12% | -$121K |
|
618
Pultegroup
PHM
$24.5B
| $826K | 0.01% |
28,743
+6,481
| +29% | +$195K |
|
619
DaVita
DVA
$15.1B
| $818K | 0.01% |
+11,776
| New | +$787K |
|
620
Kimco Realty
KIM
$17.6B
| $814K | 0.01% |
47,911
-496
| -1% | -$7.49K |
|
|
RNTX
621
Rein Therapeutics
RNTX
$67.7M
| $813K | 0.01% |
7,500
| – | – |
|
|
QVCGA
622
DELISTED
QVC Group Inc Series A
QVCGA
| $806K | 0.01% |
+782
| New | +$865K |
|
623
XPO
XPO
$25B
| $805K | 0.01% |
+23,241
| New | +$843K |
|
624
Hormel Foods
HRL
$13.9B
| $802K | 0.01% |
21,563
+3,990
| +23% | +$143K |
|
625
Western Union
WU
$2.57B
| $790K | 0.01% |
38,844
+6,170
| +19% | +$123K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2018 Portfolio in Review
As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.
- Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
- Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
- Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
- Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
- Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
- Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
- Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.
Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.